share_log

Cantor Fitzgerald Reiterates Overweight on Mesoblast, Maintains $17 Price Target

Benzinga ·  Sep 21, 2023 20:58

Cantor Fitzgerald analyst Louise Chen reiterates Mesoblast (NASDAQ:MESO) with a Overweight and maintains $17 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment